ATE316089T1 - Isoindolderivate - Google Patents

Isoindolderivate

Info

Publication number
ATE316089T1
ATE316089T1 AT00955004T AT00955004T ATE316089T1 AT E316089 T1 ATE316089 T1 AT E316089T1 AT 00955004 T AT00955004 T AT 00955004T AT 00955004 T AT00955004 T AT 00955004T AT E316089 T1 ATE316089 T1 AT E316089T1
Authority
AT
Austria
Prior art keywords
oxygen atom
pharmaceutically acceptable
acceptable salt
hydrogen atoms
represent hydrogen
Prior art date
Application number
AT00955004T
Other languages
English (en)
Inventor
Toshio Nagase
Tomoharu Iino
Yoshiyuki Sato
Teruyuki Nishimura
Jun-Ichi Eiki
Original Assignee
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd
Application granted granted Critical
Publication of ATE316089T1 publication Critical patent/ATE316089T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT00955004T 1999-08-25 2000-08-25 Isoindolderivate ATE316089T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23900499 1999-08-25

Publications (1)

Publication Number Publication Date
ATE316089T1 true ATE316089T1 (de) 2006-02-15

Family

ID=17038474

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00955004T ATE316089T1 (de) 1999-08-25 2000-08-25 Isoindolderivate

Country Status (7)

Country Link
US (2) US6608098B1 (de)
EP (1) EP1207161B1 (de)
AT (1) ATE316089T1 (de)
AU (1) AU6729600A (de)
CA (1) CA2382528A1 (de)
DE (1) DE60025616T2 (de)
WO (1) WO2001014386A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
WO2002066479A1 (en) * 2001-02-23 2002-08-29 Banyu Pharmaceutical Co.,Ltd. Novel isoindole derivatives
GB0121709D0 (en) * 2001-09-07 2001-10-31 Imp College Innovations Ltd Food inhibition agent
ES2320979T3 (es) 2001-09-24 2009-06-01 Imperial Innovations Limited Pyy-36 para la reduccion o prevencion de la obesidad.
US8058233B2 (en) * 2002-01-10 2011-11-15 Oregon Health And Science University Modification of feeding behavior using PYY and GLP-1
JP4733922B2 (ja) 2002-01-10 2011-07-27 インペリアル・イノベ−ションズ・リミテッド 摂食行動の修正
GB0300571D0 (en) 2003-01-10 2003-02-12 Imp College Innovations Ltd Modification of feeding behaviour
CA2551178C (en) * 2003-12-24 2012-11-06 Biota Scientific Management Pty Ltd Polycyclic agents for the treatment of respiratory syncytial virus infections
JP2008531564A (ja) * 2005-02-25 2008-08-14 アイアールエム・リミテッド・ライアビリティ・カンパニー ステロイドホルモン核受容体のモジュレーターとしてのスピロ含有化合物および組成物
GB0511986D0 (en) * 2005-06-13 2005-07-20 Imp College Innovations Ltd Novel compounds and their effects on feeding behaviour
TWI423972B (zh) 2006-09-28 2014-01-21 Biota Scient Management 治療呼吸系融合細胞病毒感染之多環劑
TWI428346B (zh) * 2006-12-13 2014-03-01 Imp Innovations Ltd 新穎化合物及其等對進食行為影響
TWI508968B (zh) 2010-02-08 2015-11-21 Biota Scient Management 用於治療呼吸道融合性病毒感染的化合物
US8796303B2 (en) 2010-11-26 2014-08-05 Biota Scientific Management Pty Ltd. Imidazo[2,1-G][1,7]naphthyridines for treating respiratory syncytial virus infections
WO2012076966A1 (en) * 2010-12-10 2012-06-14 Lupin Limited Substituted thieno [3,4-b] pyrazine compounds
KR20150097660A (ko) 2012-12-19 2015-08-26 노파르티스 아게 Cftr 채널을 억제하기 위한 트리시클릭 화합물
CA2895656A1 (en) 2012-12-19 2014-06-26 Novartis Ag Tricyclic compounds as cftr inhibitors
CN105418637A (zh) * 2015-12-08 2016-03-23 彭冬青 一种治疗甲亢的药物组合物
CN120025292B (zh) * 2025-01-06 2026-04-28 江苏海洋大学 一种具有协同镇痛作用的化合物及其药物组合物、制备方法和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507863A (en) 1963-12-18 1970-04-21 Sandoz Ag Isoindolones and method for preparing same
US3928597A (en) 1974-08-15 1975-12-23 American Home Prod Hyperglycemia therapy
US4701208A (en) * 1983-08-02 1987-10-20 American Cyanamid Company Dihydroimidazopyrrolopyridine, quinoline, thieno- and furo[2,3-b]pyridine, dihydrothieno- and furo[2,3-b]-pyridine, thieno- and furo[3,2-b]pyridine and dihydrothieno- and furo[3,2-b]pyridine herbicides and method for preparation thereof
DE3520390A1 (de) 1984-07-07 1986-02-06 Bayer Ag, 5090 Leverkusen Imidazo-pyrrolo-pyridin-derivate
EP0183993A3 (de) 1984-11-16 1987-12-09 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft 2H-Imidazo[1',2':1,2]pyrrolo[3,4-b]pyridine und deren Verwendung als Unkrautbekämpfungsmittel
EP0195745B1 (de) 1985-03-12 1990-09-12 Ciba-Geigy Ag Heterocyclisch kondensierte Pyridin-Verbindungen als Herbizide
US4717414A (en) 1986-08-08 1988-01-05 Ppg Industries, Inc. Herbicidally active imidazopyrrolo-pyridine (or benzene) derivatives
DE3634952A1 (de) 1986-10-14 1988-04-21 Bayer Ag Imidazo-pyrrolo-pyridin-derivate
JPS63295575A (ja) 1987-05-26 1988-12-01 Nissan Chem Ind Ltd イミダゾピロロピリジン誘導体、その製造法及び除草剤
EP0296109A3 (de) 1987-06-18 1989-12-20 Ciba-Geigy Ag 2-(Imidazolin-2-yl)nicotinsäurederivate
DE4108395A1 (de) 1991-03-15 1993-01-28 Boehringer Mannheim Gmbh Verwendung von oxazolo-(2,3-a)isoindol-und imidazo(2,1-a)-isoindol-derivaten als antivirale arzneimittel sowie neue oxazolo(2,3-a)isoindol-derivaten

Also Published As

Publication number Publication date
DE60025616T2 (de) 2006-11-30
WO2001014386A1 (en) 2001-03-01
US6777410B2 (en) 2004-08-17
EP1207161A4 (de) 2002-10-30
US20040053923A1 (en) 2004-03-18
EP1207161A1 (de) 2002-05-22
EP1207161B1 (de) 2006-01-18
US6608098B1 (en) 2003-08-19
CA2382528A1 (en) 2001-03-01
AU6729600A (en) 2001-03-19
DE60025616D1 (de) 2006-04-06

Similar Documents

Publication Publication Date Title
DE60025616D1 (de) Isoindolderivate
DK1221444T3 (da) Kondenserede imidazolforbindelser og lægemidler mod diabetes mellitus
NO20020968D0 (no) Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
DE69820248D1 (de) Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
DK1029853T3 (da) Heteroaromatiske bicykliske derivativer, der er egnede som anticancermidler
EP1008588A4 (de) 11,15-o-dialkylprostaglandin-e-derivate, verfahren zu ihrer herstellung und arzneimittel, die diese als aktiven inhaltsstoff enthalten
EP1217001A4 (de) Chinuclidin-verbindungen und medikamente die diese als aktive wirkstoffe enthalten
RU94036772A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования эндометриоза
NO20014925D0 (no) Farmasöytiske forbindelser
AU4396899A (en) Remedies for diabetes
PL359415A1 (en) Oxadiazole derivatives having anticancer effects
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
WO2003053971A8 (en) Pyridoquinoxaline antivirals
ATE240949T1 (de) Epoxysuccinamid-derivate oder ihre salze
NO323556B1 (no) Forbindelser, farmasoytiske preparater som omfatter forbindelsene, og anvendelse av forbindelsene ved fremstilling av antibakterielle medikamenter.
AU2408602A (en) Indole derivatives and use thereof in medicines
IL169577A0 (en) Oligosaccharide derivatives and pharmaceutical compostions containing the same
NO993911L (no) Remedier/Forebygningsmidler for Õndedrettssykdommer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties